Real World Prostate Cancer Registry
Part of paid clinical trials in Cincinnati, Ohio.
- Sponsor
- Cincinnati Cancer Advisors
- Study ID
- NCT06355336
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Prostate cancer is the most common cancer diagnosed in men in the USA with 268,490 cases diagnosed in 2022 constituting 27% of male cancers and 34,500 deaths (11%) occurred in same year.1 Prostate cancer is a very heterogeneous disease that has different presentations, molecular and pathological features, stages, and disease biology. The treatment options are dependent on the disease stage, its features, and the patient's condition and preferences. The disease outcome also varies significantly due to the previous heterogeneity of the features in addition to other social determinants of health. Therefore, it is critical to obtain real-world data that reflects the actual patterns of prostate cancer presentation, work up, management, and outcome. Real World Prostate Cancer Registry (RWPCR) aims at compiling real world data from patients presented with prostate cancer in the tristate area. The data collection will be prospective and longitudinal including patients' demographics and disease characteristics, work up, management, and outcome.
Key Dates
- Start date
- Mar 18, 2024
- Status verified
- May 2025
- Primary completion
- Mar 18, 2034
- Completion
- Mar 18, 2034
Study Design
- Enrollment
- 1,000 participants (estimated)
Primary Outcome Measure
To determine practice patterns for prostate cancer in the region. [ Time Frame: 10 years ]
Central Contacts
- Abdul Jazieh, MD, MPH5137312273
- Amy Barber5137312273
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cincinnati Cancer Advisors | Cincinnati | Ohio | 45212 | Abdul R Jazieh, MD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cincinnati, OH
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPHASE2 · Recruiting · Astellas Pharma Global Development, Inc. · Anchorage, Alaska
- International Registry for Men With Advanced Prostate Cancer (IRONMAN)Recruiting · Prostate Cancer Clinical Trials Consortium · Birmingham, Alabama
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPHASE1 · Recruiting · Amgen · Duarte, California